7Baggers

Applied DNA Sciences Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20190331 20190630 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 -4.81-3.24-1.68-0.111.453.024.586.15Milllion

Applied DNA Sciences Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2006-09-30 2006-06-30 
  revenue891,164 779,736 2,917,341 4,407,614 5,262,752 3,559,317 4,296,371 6,147,283 4,165,706 3,039,735 1,700,320 2,671,542 1,616,141 313,989 431,516 552,473 633,519 1,672,842 2,053,457 778,468 884,322 1,195,365 1,016,355 1,043,946 647,677 1,145,497 1,797,382 905,373 903,008 1,636,095 652,896 573,322 1,324,114 3,980,265 2,267,671 1,518,761 1,241,802 645,526 841,197 637,146 597,354 729,105 644,842 344,605 317,670 290,814 528,574 518,402 516,904 280,878 229,710 140,443 317,817 89,659 170,195 187,275 72,715 60,992 22,925 64,670 146,575 289,415 252,691 252,691 123,167 15,639 18,900 
  cost of revenue660,067 700,740 1,648,023 2,600,179 2,885,069 3,142,558 3,257,113 3,658,798 3,056,568 2,949,759 550,457 356,610 242,562 154,483 154,804 179,582 232,031 320,105 270,883 133,141 153,485 250,659 252,562 372,153 331,440 272,680 232,348 297,372 274,832 441,971 121,260 34,364 14,154 20,210 14,801 19,658 14,036 14,434 6,382 2,521 8,594 43,741 46,839 50,489 50,489 27,890 15,639 15,639 
  gross profit231,097 78,996 1,269,318 1,807,435 2,377,683 416,759 1,039,258 2,488,485 1,109,138 89,976 1,149,863 2,314,932 1,373,579 159,506 276,712 372,891 401,488 1,352,737 1,782,574 645,327 730,837 944,706 763,793 671,793 316,237 872,817 1,565,034 608,001 628,176 1,194,124 531,636 573,322 1,324,114 3,980,265 2,267,671 1,518,761 1,241,802 645,526 841,197 637,146 597,354 729,105 644,842 344,605 317,670 290,814 528,574 518,402 516,904 246,514 229,710 126,289 297,607 74,858 150,537 173,239 58,281 54,610 20,404 56,076 102,834 242,576 202,202 202,202 95,277 3,261 
  operating expenses                                                                   
  research and development935,815 938,907 836,123 988,744 971,304 912,881 863,025 1,070,041 1,080,096 1,113,393 1,029,627 874,055 748,365 1,239,720 814,599 703,018 564,426 886,668 719,668 651,377 709,564 716,692 625,006 669,813 740,067 524,746 603,095 635,893 518,628 832,227 1,077,916 729,079 471,934 673,637 310,093 373,380 278,288 215,334 266,331 359,782 459,304 183,348 184,981 176,485 147,666 158,141 99,958 96,097 78,473 107,231 47,988 92,951 20,706 31,017 18,142 20,654 6,148 3,710 28,306 40,860 62,529 33,790 19,816 19,816 36,326 77,915 
  sales, general and administrative                                                                   
  total operating expenses4,020,163 4,249,817 4,128,427 4,511,459 3,596,661 4,786,226 3,876,992 4,482,818 5,742,269 3,725,476 4,517,351 4,630,923 4,346,681 4,212,085 3,465,506 3,055,099 3,012,906 3,216,582 3,214,206 3,277,964 3,926,996 4,410,107 3,630,163 2,811,697 3,490,869 3,715,663 4,167,353 4,029,632 4,581,522 3,603,906 3,953,977 4,020,529 4,244,642 4,468,179 3,939,887 3,397,666 5,059,504 3,488,270 3,328,207 3,764,331 4,410,097 3,081,432 3,488,076 2,952,722 2,689,828 2,057,821 1,955,797 2,019,451 2,329,274 4,057,700 1,720,668 1,790,045 1,422,528 1,935,316 2,621,084 1,375,837 1,641,729 1,248,337 1,116,069 1,830,039 2,935,522 1,054,936 1,081,199 1,081,199 1,842,399 9,657,325 1,527,791 
  operating income-3,789,066 -4,170,821 -2,859,109 -2,704,024 1,418,822 -4,369,467 -2,837,734 -1,994,333 -4,633,131 -4,457,241 -3,367,488 -2,315,991 -2,973,102 -4,052,579 -3,188,794 -2,682,208 -2,611,418 -1,863,845 -1,431,632 -2,632,637 -3,196,159 -3,465,401 -2,866,370 -2,139,904 -3,174,632 -2,842,846 -2,602,319 -3,421,631 -3,953,346 -2,409,782 -3,422,341 -3,447,207 -2,920,528 -487,914 -1,672,216 -1,878,905 -3,817,702 -2,842,744 -2,487,010 -3,127,185 -3,812,743 -2,352,327 -2,843,234 -2,608,117 -2,372,158 -1,767,007 -1,427,223 -1,501,049 -1,812,370 -3,776,822 -1,490,958 -1,663,756 -1,124,921 -1,860,458 -2,470,547 -1,202,598 -1,583,448 -1,193,727 -1,095,665 -1,773,963 -2,832,688 -812,360 -878,997 -878,997 -1,747,122 -9,657,325 -1,524,530 
  net income-1,182,857 -3,592,264 -3,099,766 588,343 -3,843,372 -773,067 -1,124,221 -1,127,444 -4,721,766 -4,511,093 -3,448,993 -1,516,800 -4,809,556 -4,122,933 -3,289,450 -2,952,125 -2,662,711 -1,224,135 -1,477,911 -2,686,757 -3,234,320 -3,475,283 -2,887,723 -2,146,209 -3,183,712 -2,854,678 -2,610,849 -3,428,856 -3,961,384 -2,415,076 -3,367,011 -3,467,623 -2,926,270 -496,034 -1,670,882 -1,885,582 -7,828,644 -2,105,518 -1,919,057 -2,750,436 -6,291,650 -3,718,471 -2,135,612 -3,127,631 -8,704,757 -1,767,280 -1,429,645 -1,543,882 -2,409,905 -4,417,364 -2,154,995 -2,598,669 -1,344,096 -2,115,755 -2,596,935 -1,389,202 -1,808,008 -1,446,431 -1,330,680 10,037,703 -3,316,014 -1,815,748 -1,528,719 -1,528,719 -2,132,744 -5,868,722 -5,611 

We provide you with 20 years income statements for Applied DNA Sciences stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Applied DNA Sciences stock. Explore the full financial landscape of Applied DNA Sciences stock with our expertly curated income statements.

The information provided in this report about Applied DNA Sciences stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.